If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrown Group Regulatory News (BWNG)

  • This share is currently suspended. It was suspended at a price of 39.70
  • There is currently no data for BWNG

Form 8.5 (EPT/RI)-Brown (N.) Group plc

25 Oct 2024 08:02

Form 8.5 (EPT/RI)-Brown (N.) Group plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBrown (N.) Group plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is sole financial adviser to Joshua Alliance on his proposed takeover offer for Brown (N.) Group plc
(d) Date dealing undertaken:24th October 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary Shares Purchases 39,000 39.30 39.30

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:25th October 2024
Contact name:Priyali Bhattacharjee
Telephone number:+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
18th Jun 20247:00 amRNSAnnual Report and Accounts and Notice of AGM
6th Jun 20247:00 amRNSFinal Results
29th Apr 20247:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSTrading Statement
16th Oct 202311:03 amRNSDirector/PDMR Shareholding
12th Oct 20237:00 amRNSInterim Results
7th Sep 202312:13 pmRNSN Brown announces partnership with Sainsbury’s
16th Aug 20231:59 pmRNSHolding(s) in Company
15th Aug 20232:02 pmRNSHolding(s) in Company
7th Aug 20233:30 pmRNSGrant of Nil Cost Options
2nd Aug 20237:00 amRNSIssue of equity and total voting rights
26th Jul 20231:09 pmRNSHolding(s) in Company
11th Jul 202311:59 amRNSHolding(s) in Company
10th Jul 20235:12 pmRNSResults of AGM and Confirmation of Board Changes
21st Jun 20234:49 pmRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSTrading Statement
15th Jun 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
13th Jun 20239:43 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSConfirmation of CFO change and Board appointment
6th Jun 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSNotice of Results
24th Apr 20238:32 amRNSHolding(s) in Company
5th Apr 20237:00 amRNSDirectorate Change
29th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSDominic Appleton appointed CFO Designate
8th Feb 20234:11 pmRNSHolding(s) in Company
7th Feb 20231:14 pmRNSDirectorate Change
7th Feb 202311:44 amRNSDirector/PDMR Shareholding
7th Feb 202311:41 amRNSDirector/PDMR Shareholding
3rd Feb 20235:19 pmRNSDirector/PDMR Shareholding
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 202312:28 pmRNSHolding(s) in Company
31st Jan 202311:06 amRNSDirector/PDMR Shareholding
30th Jan 20232:55 pmRNSHolding(s) in Company
27th Jan 20235:09 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20233:10 pmRNSHolding(s) in Company
23rd Jan 20233:06 pmRNSDirector/PDMR Shareholding
20th Jan 20235:37 pmRNSDirector/PDMR Shareholding
19th Jan 20234:42 pmRNSHolding(s) in Company
19th Jan 20234:38 pmRNSDirector/PDMR Shareholding
18th Jan 20234:01 pmRNSDirector/PDMR Shareholding
18th Jan 20233:57 pmRNSDirector/PDMR Shareholding
17th Jan 20238:14 amRNSDirector/PDMR Shareholding
16th Jan 20233:30 pmRNSDirector/PDMR Shareholding
16th Jan 20237:00 amRNSHolding(s) in Company
12th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.